Firm to Release More of Diphtheria Vaccine
United Press International
ATLANTA —
Supplies of a vaccine that prevents diphtheria, whooping cough and tetanus infections have improved substantially, federal health officials said Friday.
The national Centers for Disease Control said Connaught Laboratories has decided to resume production of the vaccine and release 2.2 million doses immediately.
The CDC warned last December that the vaccine might become scarce because drug firms, faced with possible liability claims over injuries suffered by recipients, were halting production.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
